{"disease":{"id":"uncontrolled-gout","name":"uncontrolled gout"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07388498","title":"A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":270,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT04511702","title":"Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":191,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT04762498","title":"A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT04087720","title":"Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT04772313","title":"Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase Monotherapy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Amgen","has_results":true}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}